Plowchalk, David
19  results:
Search for persons X
?
1

Population PK/PD modeling of low‐density lipoprotein choles..:

Wang, Ellen Q. ; Kaila, Nitin ; Plowchalk, David...
CPT: Pharmacometrics & Systems Pharmacology.  12 (2023)  12 - p. 2013-2026 , 2023
 
?
2

Results of Bococizumab, A Monoclonal Antibody Against Propr..:

Ballantyne, Christie M. ; Neutel, Joel ; Cropp, Anne...
The American Journal of Cardiology.  115 (2015)  9 - p. 1212-1221 , 2015
 
?
 
?
6

Prediction of drug clearance in a smoking population: model..:

Plowchalk, David R. ; Rowland Yeo, Karen
European Journal of Clinical Pharmacology.  68 (2012)  6 - p. 951-960 , 2012
 
?
7

Application of CYP3A4 in vitro data to predict clinical dru..:

Youdim, Kuresh A. ; Zayed, Aref ; Dickins, Maurice...
British Journal of Clinical Pharmacology.  65 (2008)  5 - p. 680-692 , 2008
 
?
 
?
12

The effect of benzo(a)pyrene on murine ovarian and corpora ..:

Miller, Michael M. ; Plowchalk, David R. ; Weitzman, Glenn A...
American Journal of Obstetrics and Gynecology.  166 (1992)  5 - p. 1535-1541 , 1992
 
?
13

Phosphoramide mustard is responsible for the ovarian toxici..:

Plowchalk, David R. ; Mattison, Donald R.
Toxicology and Applied Pharmacology.  107 (1991)  3 - p. 472-481 , 1991
 
?
15

POLYCYCLIC AROMATIC HYDROCARBON CONCENTRATIONS FROM WATERSH..:

PLOWCHALK, DAVID R. ; ZAGORSKI, STANLEY J.
Proceedings of the Pennsylvania Academy of Science.  60 (1986)  2 - p. 174-178 , 1986
 
1-15